The mission of the Division of Bacterial Diseases (DBD) is to prevent and control illness and death from vaccine-preventable and other respiratory bacterial diseases, in the U.S. and worldwide, through excellence in epidemiologic and laboratory science. This office within the National Center for Immunization and Respiratory Diseases plays a critical role in outbreak response, epidemiology, laboratory diagnosis and pathogen characterization, vaccine development, and control of respiratory and vaccine-preventable disease nationally and globally.
Our Priorities
Improve detection, prevention, and control of respiratory and related invasive bacterial pathogens
Accelerate development, introduction, and monitoring of bacterial vaccines domestically
Accelerate development, introduction, and monitoring of bacterial vaccines globally
The Division of Bacterial Diseases serves as the primary contact regarding bacterial respiratory and vaccine-preventable diseases. In addition to serving as experts in the area of bacterial respiratory and vaccine-preventable disease issues, we also:
Assure the overall quality of the science relating to bacterial respiratory and vaccine-preventable disease
Review, prepare, and coordinate congressional testimony and briefing documents related to these diseases, and analyze programmatic and policy implications of legislative proposals
Advise CDC, OID, and NCIRD on policy matters concerning DBD programs and activities
Provide statistical methodology and participate in outbreak investigations and disease reporting systems for ongoing surveillance
Develop new methods or adapt existing methods for statistical applications in epidemiologic or laboratory research studies
Provide statistical consultation for epidemiologic and laboratory research studies
DBD publishes a newsletter to update staff and interested stakeholders about ongoing Division activities. The first issue was released in December 2008.